Gilead Sciences
GILD
1,263 hedge funds and large institutions have $116B invested in Gilead Sciences in 2014 Q2 according to their latest regulatory filings, with 163 funds opening new positions, 527 increasing their positions, 461 reducing their positions, and 83 closing their positions.
96% more first-time investments, than exits
New positions opened: 163 | Existing positions closed: 83
46% more funds holding in top 10
Funds holding in top 10: 112 → 164 (+52)
14% more repeat investments, than reductions
Existing positions increased: 527 | Existing positions reduced: 461
6% more funds holding
Funds holding: 1,189 → 1,263 (+74)
0% less capital invested
Capital invested by funds: $116B → $116B (-$569M)
24% less call options, than puts
Call options by funds: $2B | Put options by funds: $2.62B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$1.16B |
| 2 |
Norges Bank
Oslo,
Norway
|
+$780M |
| 3 |
Goldman Sachs
New York
|
+$621M |
| 4 |
ECU
Egerton Capital (UK)
London,
United Kingdom
|
+$479M |
| 5 |
OH
Orbis Holdings
Hamilton,
Bermuda
|
+$273M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$3.85B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$618M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$538M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$496M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$420M |
GILD Hedge Fund Activity: Q2 2014 in Review
1,263 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2014, worth a combined $116B — down 0.49% from $116B a quarter earlier.
Buyers outnumbered sellers: 163 funds opened new GILD positions and 83 closed out — a net gain of 80 holders — while 527 added to existing stakes and 461 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $1.16B. The largest seller was BNP Paribas Financial Markets, cutting an estimated $3.85B.
- 1,263 institutional investors held Gilead Sciences (GILD) as of Q2 2014, up from 1,189 in Q1 2014.
- Funds reported $116B of Gilead Sciences stock for Q2 2014, down 0.49% quarter-over-quarter.
- 163 funds opened new Gilead Sciences positions in Q2 2014 and 83 closed out, a net change of +80 holders.
- The largest Gilead Sciences buyer in Q2 2014 was Capital Research Global Investors, an estimated $1.16B added.
- The largest Gilead Sciences seller in Q2 2014 was BNP Paribas Financial Markets, an estimated $3.85B sold.
Based on aggregated 13F filings for Q2 2014.